173 related articles for article (PubMed ID: 18383828)
1. Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.
von Bueren AO; Schlumpf M; Lichtensteiger W
Anticancer Res; 2008; 28(1A):85-9. PubMed ID: 18383828
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
4. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
5. Oestrogenic and androgenic activity of triclosan in breast cancer cells.
Gee RH; Charles A; Taylor N; Darbre PD
J Appl Toxicol; 2008 Jan; 28(1):78-91. PubMed ID: 17992702
[TBL] [Abstract][Full Text] [Related]
6. 17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell lines.
Huynh PN; Carter WH; Loria RM
Cancer Detect Prev; 2000; 24(5):435-44. PubMed ID: 11129985
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Caffarel MM; Sarrió D; Palacios J; Guzmán M; Sánchez C
Cancer Res; 2006 Jul; 66(13):6615-21. PubMed ID: 16818634
[TBL] [Abstract][Full Text] [Related]
8. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
Weichselbaum RR; Hellman S; Piro AJ; Nove JJ; Little JB
Cancer Res; 1978 Aug; 38(8):2339-42. PubMed ID: 667830
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
10. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
11. Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants.
Sonnenschein C; Szelei J; Nye TL; Soto AM
Oncol Res; 1994; 6(8):373-81. PubMed ID: 7894086
[TBL] [Abstract][Full Text] [Related]
12. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
13. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
[TBL] [Abstract][Full Text] [Related]
14. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
15. Salbutamol exhibits androgenic activity in vitro.
von Bueren AO; Ma R; Schlumpf M; Lichtensteiger W
Br J Sports Med; 2007 Dec; 41(12):874-8; discussion 878. PubMed ID: 17510230
[TBL] [Abstract][Full Text] [Related]
16. [Dual effects of androgens on mammary gland].
Brettes JP; Mathelin C
Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
[TBL] [Abstract][Full Text] [Related]
17. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line.
Kramer VJ; Helferich WG; Bergman A; Klasson-Wehler E; Giesy JP
Toxicol Appl Pharmacol; 1997 Jun; 144(2):363-76. PubMed ID: 9194421
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
19. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
Breinholt V; Larsen JC
Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
[TBL] [Abstract][Full Text] [Related]
20. Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells.
Soto AM; Murai JT; Siiteri PK; Sonnenschein C
Cancer Res; 1986 May; 46(5):2271-5. PubMed ID: 3697972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
